6Karnak D,Ulubay G,Kayacan O,et al.Evaluation of CYFRA21 -1:a potential tumor marker for non-small cell lung carcinomas[J].Lung,2001,179(1):57-65.
7Ebert W,Muley T.CYFRA21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy[J].An-tieaneer Res,1999,19(4A):2669-2672.
4Teresa C P, Isabel T Z, Juan B L, et al. Tumour markers in lung cancer: does the method of obtaining the cut - off point and reference population influence diagnostic yield? [ J ]. Clinical Biochemistry, 1999, 32:467 - 472.
5Ho Y J, Hsieh J F, Tasi S C, et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma[J] .Lung, 2000, 178:75 - 80.
6Bates J, Rutherford M, Divilly M, et al. Clinical value of CYFRA21- 1, carcinoembryonic antigen and tissue polypeptideantigen in the diagnosis of lung cancer[J ]. Eur Respir J, 1997,10:2535 - 3538.
7Manual D, Antonio T, Marina P, et al. Prognostic significance of serum CA125 antigen assay in patients with non - small cell lung cancer[J ]. Cancer, 1994, 73:1368 - 1376.
8Deglorigio CM, Gott PS, Robinincz AL, et al. Neuron-specific ennlase, a marker of acute neuronal injury is increased in complex partial status epilepticus. Epilepsia 1996;37(7):606
9Fizazi K, Cojeam I, Pignon JP, et al. Nonmal serum neuron-specific enolase (NSE) is value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung cancinoma. Cancer 1998; 82:1049
10Pinson P, Joos G, Watripont P, et al. Serum neuron-specific enolase as a tumor maker in the diagnosis and follow-up of small cell lung carcer. Respiration 1997;64:102
